Nanosuspensions: a promising drug delivery strategy VB Patravale, AA Date, RM Kulkarni Journal of pharmacy and pharmacology 56 (7), 827-840, 2004 | 1154 | 2004 |
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety S Mukherjee, A Date, V Patravale, HC Korting, A Roeder, G Weindl Clinical interventions in aging 1 (4), 327-348, 2006 | 655 | 2006 |
Polymeric nanoparticles for targeted treatment in oncology: current insights RH Prabhu, VB Patravale, MD Joshi International journal of nanomedicine, 1001-1018, 2015 | 522 | 2015 |
Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery KA Shah, AA Date, MD Joshi, VB Patravale International journal of pharmaceutics 345 (1-2), 163-171, 2007 | 448 | 2007 |
Nanostructured lipid carrier (NLC) based gel of celecoxib M Joshi, V Patravale International journal of pharmaceutics 346 (1-2), 124-132, 2008 | 392 | 2008 |
Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles AA Date, MD Joshi, VB Patravale Advanced drug delivery reviews 59 (6), 505-521, 2007 | 388 | 2007 |
Novel cosmetic delivery systems: an application update VB Patravale, SD Mandawgade International journal of cosmetic science 30 (1), 19-33, 2008 | 372 | 2008 |
Formulation and evaluation of nanostructured lipid carrier (NLC)–based gel of Valdecoxib M Joshi, V Patravale Drug development and industrial pharmacy 32 (8), 911-918, 2006 | 268 | 2006 |
Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review S Mhatre, T Srivastava, S Naik, V Patravale Phytomedicine 85, 153286, 2021 | 264 | 2021 |
Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation YG Bachhav, VB Patravale International Journal of Pharmaceutics 365 (1-2), 175-179, 2009 | 255 | 2009 |
Current strategies for engineering drug nanoparticles AA Date, VB Patravale Current opinion in colloid & interface science 9 (3-4), 222-235, 2004 | 249 | 2004 |
Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations PP Desai, AA Date, VB Patravale Drug Discovery Today: Technologies 9 (2), e87-e95, 2012 | 248 | 2012 |
Development of SLNs from natural lipids: application to topical delivery of tretinoin SD Mandawgade, VB Patravale International journal of pharmaceutics 363 (1-2), 132-138, 2008 | 247 | 2008 |
Endosomal escape: a bottleneck in intracellular delivery HK Shete, RH Prabhu, VB Patravale Journal of nanoscience and nanotechnology 14 (1), 460-474, 2014 | 214 | 2014 |
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management VP Chavda, LK Vora, AK Pandya, VB Patravale Drug discovery today 26 (11), 2619-2636, 2021 | 189 | 2021 |
Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject M Joshi, S Pathak, S Sharma, V Patravale International journal of pharmaceutics 364 (1), 119-126, 2008 | 186 | 2008 |
The upcoming field of theranostic nanomedicine: an overview P Prabhu, V Patravale Journal of Biomedical Nanotechnology 8 (6), 859-882, 2012 | 170 | 2012 |
Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine AA Kale, VB Patravale AAPS pharmscitech 9, 191-196, 2008 | 169 | 2008 |
Microneedles for transdermal drug delivery: a systematic review S Dharadhar, A Majumdar, S Dhoble, V Patravale Drug development and industrial pharmacy 45 (2), 188-201, 2019 | 158 | 2019 |
Long chain lipid based tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization H Shete, V Patravale International journal of pharmaceutics 454 (1), 573-583, 2013 | 157 | 2013 |